Oncology Nursing Society

Oncologic Emergencies

Article

Hyperglycemia and Cancer: A State-of-the-Science Review

Marilyn Hammer

Susan Storey

Denise Soltow Hershey

Veronica J. Brady

Ellen Davis

Natalie Mandolfo

Ashley Leak Bryant

Jill Olausson

ONF 2019, 46(4), 459-472 DOI: 10.1188/19.ONF.459-472

Problem Identification: Hyperglycemia can increase the risk for adverse events and outcomes in patients undergoing treatment for cancer. The purposes of this state-of-the-science review were to explore the complexity of hyperglycemia in patients with cancer and to analyze physiologic mechanisms and...

Average: 5 (1 vote)

Read this Article

Article

Associated Toxicities: Assessment and Management Related to CAR T-Cell Therapy

Karen Anderson

Theresa Latchford

CJON 2019, 23(2), 13-19 DOI: 10.1188/19.CJON.S1.13-19

Background: The impressive disease response observed with chimeric antigen receptor (CAR) T-cell therapy is accompanied by the potential for unique and severe toxicities. Cytokine release syndrome (CRS) and neurologic toxicities have emerged as prominent toxicities associated with this treatment...

Average: 1 (1 vote)

Read this Article

Online Exclusive Article

Article

Chlorhexidine Gluconate Baths: Supporting Daily Use to Reduce Central Line–Associated Bloodstream Infections Affecting Immunocompromised Patients

Gladys N. Jusino-Leon

Linda Matheson

Lydia Forsythe

CJON 2019, 23(2), E32-E38 DOI: 10.1188/19.CJON.E32-E38

Background: Chlorhexidine gluconate (CHG) has a broad-spectrum antimicrobial property that has proven to be effective in prolonging skin antisepsis and decreasing pathogens often seen in oncology units. Objectives: The aim was to reduce the incidence of central line–associated bloodstream...

Average: 5 (2 votes)

Read this Article

Essentials

Thrombopoietin Receptor Agonists: Eltrombopag and Romiplostim for the Treatment of Chronic Immune Thrombocytopenia Purpura

Katie Atkinson

CJON 2019, 23(2), 212-216 DOI: 10.1188/19.CJON.212-216

The thrombopoietin receptor agonists, eltrombopag and romiplostim, are second-line agents used to treat chronic immune thrombocytopenia purpura (ITP) in adults and children. ITP is a rare autoimmune disease and hematologic disorder characterized by reduced platelet counts that can result in...

No votes yet

Read this Article

Supportive Care

Venous Flare Reactions: A Case Report of Reactions Following Etoposide Infusion

Jaya Mini Gill

Janice Frost

Rachelle Park

Marlon Garzo Saria

CJON 2018, 22(6), 597-599 DOI: 10.1188/18.CJON.597-599

Venous flare reaction, a localized allergic response associated with the administration of an irritant, is one of the most common chemotherapy infusion–related reactions. Etoposide, a drug commonly used in patients with lung cancer, has been reported to be an irritant with vesicant properties...

Average: 4 (1 vote)

Read this Article